FTCM
PFE icon

Fir Tree Capital Management’s Pfizer PFE Stock Holding History

Fir Tree Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,067,913
Closed -$30M – 64
2016
Q1 		$30M Buy
+1,067,913
New +$30.5M 1.14% 17

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fir Tree Capital Management's PFE Position: Q2 2016 in Review

Fir Tree Capital Management sold out of Pfizer (PFE) in Q2 2016, closing a stake of 1,067,913 shares — an estimated $30M sold.

Fir Tree Capital Management first reported a position in PFE in Q1 2016 and held it in 1 quarter. The position peaked at $30M in Q1 2016. 1,991 funds tracked by Wall St. Rank hold PFE as of Q2 2016.

  • Fir Tree Capital Management reported no remaining Pfizer position as of Q2 2016 after selling out during the quarter.
  • Fir Tree Capital Management sold 1,067,913 Pfizer shares in Q2 2016, an estimated $30M.
  • Fir Tree Capital Management first reported a position in Pfizer in Q1 2016 and held it in 1 quarter.
  • Fir Tree Capital Management's Pfizer position peaked at $30M in Q1 2016.
  • 1,991 funds tracked by Wall St. Rank held Pfizer as of Q2 2016.

Based on Fir Tree Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.